Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study
Resource Type
Article
Authors
Kelly, Kevin R ; Ailawadhi, Sikander ; Siegel, David S ; Heffner, Leonard T ; Somlo, George ; Jagannath, Sundar ; Zimmerman, Todd M ; Munshi, Nikhil C ; Madan, Sumit ; Chanan-Khan, Asher ; Lonial, Sagar ; Chandwani, Suraj ; Minasyan, Ashot ; Ruehle, Markus ; Barmaki-Rad, Farima ; Abdolzade-Bavil, Afsaneh ; Rharbaoui, Faiza ; Herrmann-Keiner, Eva ; Haeder, Thomas ; Wartenberg-Demand, Andrea ; Anderson, Kenneth C
Source
In The Lancet Haematology November 2021 8(11):e794-e807
Subject
Primary Research Articles
Language
ISSN
2352-3026